Noble Wealth Management PBC’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
LMFP
CIM
ATO
CGH
Noble Wealth Management PBC's GILD Position: Q2 2026 in Review
Noble Wealth Management PBC opened a new position in Gilead Sciences (GILD) in Q2 2026: 9 shares worth $1.14K. The stake represents ﹤0.01% of the portfolio and ranks #680 among its holdings. This is a return to the name: Noble Wealth Management PBC previously reported a position in GILD as recently as Q1 2025.
Noble Wealth Management PBC first reported a position in GILD in Q4 2024 and has held it in 3 quarters since. The position peaked at $4.48K in Q1 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Noble Wealth Management PBC held 9 shares of Gilead Sciences worth $1.14K as of Q2 2026.
- Gilead Sciences was a new Noble Wealth Management PBC position in Q2 2026.
- Gilead Sciences made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q2 2026, its #680 holding.
- Noble Wealth Management PBC first reported a position in Gilead Sciences in Q4 2024 and has held it in 3 quarters since.
- Noble Wealth Management PBC's Gilead Sciences position peaked at $4.48K in Q1 2025.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Noble Wealth Management PBC's 13F filing for Q2 2026, filed 1 Jul 2026.